Fluticasone Propionate Nasal Spray (FLONASE(R)) will be the first product marketed under this arrangement MASON, Ohio, March 11 /PRNewswire/ -- Prasco Laboratories, announced today it has entered into a marketing and distribution agreement with GlaxoSmithKline (NYSE: GSK).

High doses of inhaled corticosteroids are effective in reducing the severity and duration of asthma attacks triggered by colds, Canadian researchers said. Study leader Dr.

JEFFERSON, N.C., Dec. 22 /PRNewswire/ -- Next Safety has developed a proprietary platform that delivers nicotine and a number of other drugs including albuterol and the components of Advair(TM), fluticasone propionate and salmeterol xinofoate, in air timed to the user's inhalation.

SkyePharma Announces Successful Completion of FlutiformTM U.S. Clinical Trial Programme LONDON, UK, 23 October, 2008 - SkyePharma PLC (LSE: SKP) today announces that the final U.S.

SkyePharma has announced that its development and marketing partner Mundipharma has successfully completed two Phase III clinical studies for the European development program for Flutiform, both of which have shown positive results.